Current Advance in Targeted Treatment and Immunotherapy for BRAF-mutant 
Advanced Non-small Cell Lung Cancer

This article reviewed the progress of immunological and targeted therapy for patients with BRAF-mutated NSCLC. 
 DOI: 10.3779/j.issn.1009-3419.2021.101.29
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research